Activated Cardiac Fibroblasts Control Contraction of Human Fibrotic Cardiac Microtissues by a β-Adrenoreceptor-Dependent Mechanism
Cardiac fibrosis represents a serious clinical problem. Development of novel treatment strategies is currently restricted by the lack of the relevant experimental models in a human genetic context. In this study, we fabricated self-aggregating, scaffold-free, 3D cardiac microtissues using human indu...
Main Authors: | Przemysław Błyszczuk, Christian Zuppinger, Ana Costa, Daria Nurzynska, Franca Di Meglio, Mara Stellato, Irina Agarkova, Godfrey L. Smith, Oliver Distler, Gabriela Kania |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/5/1270 |
Similar Items
-
iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development
by: Eline Simons, et al.
Published: (2023-01-01) -
Modelling the pathology and treatment of cardiac fibrosis in vascularised atrial and ventricular cardiac microtissues
by: Jasmeet S. Reyat, et al.
Published: (2023-09-01) -
From Human Pluripotent Stem Cells to 3D Cardiac Microtissues: Progress, Applications and Challenges
by: Mariana A. Branco, et al.
Published: (2020-08-01) -
Comparative Gene Expression Analyses Reveal Distinct Molecular Signatures between Differentially Reprogrammed Cardiomyocytes
by: Yang Zhou, et al.
Published: (2017-09-01) -
BEaTS-β: an open-source electromechanical bioreactor for simulating human cardiac disease conditions
by: Hiroki Takaya, et al.
Published: (2023-09-01)